#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angelman's syndrome Oesophageal adenocarcinoma stage III PIK3CA-activated mutation Advanced systemic mastocytosis Choroid melanoma Retinoblastoma Noonan syndrome Waldenstrom's macroglobulinaemia recurrent Pancreatic neuroendocrine tumour Neuroblastoma Mantle cell lymphoma stage IV Glycogen storage disease type II Precursor T-lymphoblastic lymphoma/leukaemia recurrent Anal cancer recurrent Mucous membrane pemphigoid More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Diagnostics Haemophilia B with anti factor IX – Diagnostics Idiopathic inflammatory myopathy Short-bowel syndrome – Treatment Mucopolysaccharidosis III – Trials in Disease Mucous membrane pemphigoid – Life with Disease Alveolar rhabdomyosarcoma Acute respiratory distress syndrome – Diagnostics Splenic marginal zone lymphoma – Diagnostics Medulloblastoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM SELENITE PENTAHYDRATE Azathioprine Carbetocin Sodium Cromoglicate Cft1946 Tinzaparin Sodium Purified Egg Phospholipids Belzutifan Mitapivat Estradiol Hemihydrate Pemafibrate Prednisolone Sodium Succinate Gsk3739937 Crisantaspase Serine Flecainide Nadunolimab Rbl027.2 GSKVX000000030918 Ursodeoxycholic Acid More therapies…

    Learn about Your Condition

    Peritoneal neoplasm Abdominal wall pain Coma Prinzmetal angina Cardiac failure congestive Myxofibrosarcoma Parkinson's disease Neuromuscular scoliosis Intellectual disability B-cell type acute leukaemia Psychotic disorder Eosinophilic oesophagitis Mesothelioma malignant Pericarditis Infectious pleural effusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Safety and Effects of Dasatinib for Reducing Inflammation in People with HIV on Antiretroviral Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dasatinib
    Spain

  • Study on the Safety of Doravirine and Islatravir for HIV Patients Who Previously Participated in Doravirine/Islatravir Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    France Italy

  • Study Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated

    Not recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Bictegravir
    • Emtricitabine
    • Lenacapavir
    France Germany Italy Spain

  • Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Abatacept
    Cyprus Denmark France Germany Greece Ireland +3

  • Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cobicistat
    • Darunavir
    • Bictegravir
    Belgium France Germany Ireland Italy Spain

  • Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Bictegravir
    Austria Belgium France Germany Italy The Netherlands +2
Previous Page
1 … 43 44 45 46 47 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!